Nasal administration of the LH-RH analog Leuprolide

2004
OA: closed
AI-generated summary by qwen3.7-flash, 2026-09-12

This invention describes a nasal leuprolide composition containing chitosan for treating conditions such as endometriosis, prostate cancer, and uterine leiomyomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, such as endometriosis, prostate cancers, hypogonadism, pre-menstrual syndrome, or uterine leiomyomas.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-14T06:11:53.302379+00:00